Gut dysbiosis is often linked to persistent multi-system symptoms after SARS-CoV-2 infections or post-acute COVID-19 syndrome. In data presented during the 2023 Digestive Disease Week (DDW) in Chicago as a late-breaking abstract, a team, led by Raphaela Iris Lau, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, assessed the effects of gut microbiome modulation on the alleviation of post-acute COVID-19 syndrome. Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more